Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
133%(4 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_1
2
40%
Ph phase_3
1
20%
Ph not_applicable
2
40%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (40.0%)
Phase 31 (20.0%)
N/A2 (40.0%)

Trials by Status

completed360%
not_yet_recruiting120%
terminated120%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable

Comparison of Pregnancy Outcomes in Women with Polycystic Ovarian Syndrome with and Without Glucophage

NCT06713967
completedphase_3

Metformin Therapy for Overweight Adolescents With Type 1 Diabetes

NCT01881828
terminatednot_applicable

Metformin for the Treatment of Premature Pubarche in Girls

NCT01316042
completedphase_1

Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single Tablets

NCT01844531
completedphase_1

Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects

NCT01068730

Clinical Trials (5)

Showing 5 of 5 trials
NCT06713967Not Applicable

Comparison of Pregnancy Outcomes in Women with Polycystic Ovarian Syndrome with and Without Glucophage

Not Yet Recruiting
NCT01881828Phase 3

Metformin Therapy for Overweight Adolescents With Type 1 Diabetes

Completed
NCT01316042Not Applicable

Metformin for the Treatment of Premature Pubarche in Girls

Terminated
NCT01844531Phase 1

Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single Tablets

Completed
NCT01068730Phase 1

Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5